Matt Hemming
@SarcomaLab
Medical oncologist and physician scientist focused on sarcoma @UMassChan and @UMassCancerCtr
Now out in @CR_AACR: We mine the epigenetic underpinnings of #AlveolarSoftPartSarcoma utilizing patient samples, preclinical models, and functional tags (dTAG, BioID) to define the oncogenic transcriptional program driven by ASPSCR1::TFE3 and actionable therapeutic liabilities:
With @NIH cuts making research funding harder to secure, CRI is stepping up! We’re committing $2.5M to support 10 additional postdocs so that promising #CancerResearch doesn’t get left behind. Learn more: bit.ly/4iEQNsJ
Read Pukkila-Worley, MD, is the new director of the MD/PhD program: direc.to/n8PN Dr. Pukkila-Worley has mentored dozens of MD/PhD graduate students since joining @UMassChan in 2014. The @RPWLab studies host-pathogen interactions and bacterial pathogenesis. @UMassMDPhD
🗣️ We're hiring a Director of Preclinical Research! This is an exciting opportunity for an oncology R&D leader to make a tangible impact in the lives of patients in urgent need of new treatment options. More info: chordoma.org/team/careers/
PhD candidate Favour Akabogu is working to develop new therapies for a rare type of sarcoma called gastrointestinal stromal tumor (GIST), a tumor that develops throughout the gastrointestinal tract: brnw.ch/21wTruo #StudentSpotlight #Research #PhD @SarcomaLab
Terrific spotlight by @UMassChan on PhD candidate @FavourFavvycool highlighting Favour’s outstanding accomplishments and work on #sarcoma & #GIST, and well-deserved accolades for her research and presentations! umassmed.edu/news/news-arch…
Another study- my recent work on Friedreich Ataxia just went online! @UMassChan With a targeted RNAi screen, we uncovered ROCK1/2 as key epigenetic silencers of FXN. jneurosci.org/content/early/… #FriedreichAtaxia #frataxinreactivation #DrugRepurposing
Congratulations to @YiHsuanH83 on passing her qualifying exam @UMassChan and advancing to PhD Candidacy in the SarcomaLab! We’re inspired by your dedication to transformative #Sarcoma research!
🧬 Genetic Predisposition in Sarcoma Up to 20% #sarcoma may be assoc. with predisposition genes In our 📝 we review evidence on genetic predis. & how it may influence Rx decisions & management inc. surgery, radiotherapy, systemic Rx & surveillance 1/4 thelancet.com/journals/eclin…
Kudos to Kashmir hometown hero @ShahidBanday_ for this great profile of his work and career in sarcoma research! The future of #sarcoma research is bright, congratulations Shahid! risingkashmir.com/kashmir-born-s…
Congratulations to Favour Akabogu @FavourFavvycool for being awarded the Vertex Biomedical Science Career Scholarship! Favour also won FIRST PRIZE for her oral presentation on #gastrointestinalstromaltumor #sarcoma at the New England Science Symposium @NESS_News!
tandfonline.com/doi/full/10.10… Our review paper on rare GIST is out! 🧬#GIST #sarcoma Leonidas Mavroeidis @anapolitano_md @RobinL_Jones @royalmarsdenNHS @tandfonline
RFP for LMS-specific grant proposals: Submission to the National Leiomyosarcoma Foundation. Details here: leiomyosarcoma.info/general-resear…
🚀 We just launched the brand-new #KinaseLibrary website, directly connected to the recently released Python package! Explore kinase-substrate relationships, run enrichment analyses, and visualize phosphoproteomics data—no coding required! kinase-library.phosphosite.org @KinaseLibrary
Strong argument for inclusion of patients with advanced dedifferentiated liposarcoma in trials: Experimental therapy results in better overall survival (37.9 vs 10.4 months; p=0.01) compared to doxorubicin-based therapy in retrospective real-world series doi.org/10.1186/s12885…
The National Leiomyosarcoma Foundation is pleased to announce that it will be funding a two-year LMS research grant for 2026-2027. Please see the following link for information on applying, and we look forward to receiving your LMS-specific proposals! leiomyosarcoma.info/general-resear…
We are looking for another #sarcoma Medical Oncologist to join our team in downtown Chicago!! Graduating fellows: you are interested in an academic position in Chicago, we can train you up on the sarcoma part of the job! job is now posted: facultyrecruiting.northwestern.edu
Terrific spotlight on Sarcoma Researcher Extraordinaire @ShahidBanday_ @UMassChan #Sarcoma umassmed.edu/medicine/resea…
